Leuthold Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.82M | Buy |
56,091
+1,033
| +2% | +$145K | 0.83% | 38 |
|
|
2025
Q4 | $6.76M | Buy |
55,058
+12,422
| +29% | +$1.51M | 0.73% | 49 |
|
|
2025
Q3 | $4.73M | Buy |
+42,636
| New | +$4.85M | 0.52% | 76 |
|
|
2021
Q1 | – | Sell |
-43,597
| Closed | -$2.54M | – | 186 |
|
|
2020
Q4 | $2.54M | Sell |
43,597
-44,613
| -51% | -$2.69M | 0.33% | 107 |
|
|
2020
Q3 | $5.57M | Sell |
88,210
-1,745
| -2% | -$121K | 0.76% | 43 |
|
|
2020
Q2 | $6.92M | Sell |
89,955
-2,261
| -2% | -$173K | 1.03% | 29 |
|
|
2020
Q1 | $6.89M | Sell |
92,216
-7,612
| -8% | -$526K | 1.24% | 22 |
|
|
2019
Q4 | $6.49M | Sell |
99,828
-3,803
| -4% | -$248K | 0.84% | 42 |
|
|
2019
Q3 | $6.57M | Buy |
103,631
+35,703
| +53% | +$2.33M | 0.86% | 42 |
|
|
2019
Q2 | $4.59M | Sell |
67,928
-4,339
| -6% | -$285K | 0.59% | 62 |
|
|
2019
Q1 | $4.7M | Buy |
72,267
+28,658
| +66% | +$1.9M | 0.63% | 64 |
|
|
2018
Q4 | $2.73M | Sell |
43,609
-3,032
| -7% | -$212K | 0.39% | 96 |
|
|
2018
Q3 | $3.6M | Buy |
+46,641
| New | +$3.52M | 0.39% | 98 |
|
|
2018
Q1 | – | Sell |
-95,395
| Closed | -$6.83M | – | 203 |
|
|
2017
Q4 | $6.83M | Buy |
95,395
+23,508
| +33% | +$1.79M | 0.68% | 52 |
|
|
2017
Q3 | $5.82M | Sell |
71,887
-103
| -0.1% | -$7.88K | 0.59% | 56 |
|
|
2017
Q2 | $5.09M | Sell |
71,990
-2,521
| -3% | -$168K | 0.55% | 65 |
|
|
2017
Q1 | $5.06M | Sell |
74,511
-1,659
| -2% | -$117K | 0.55% | 61 |
|
|
2016
Q4 | $5.46M | Sell |
76,170
-5,883
| -7% | -$437K | 0.61% | 53 |
|
|
2016
Q3 | $6.49M | Buy |
+82,053
| New | +$6.67M | 0.68% | 52 |
|
|
2016
Q2 | – | Sell |
-73,750
| Closed | -$6.78M | – | 225 |
|
|
2016
Q1 | $6.78M | Buy |
73,750
+21,473
| +41% | +$1.94M | 0.74% | 49 |
|
|
2015
Q4 | $5.29M | Buy |
52,277
+15,934
| +44% | +$1.66M | 0.56% | 63 |
|
|
2015
Q3 | $3.57M | Sell |
36,343
-5,062
| -12% | -$562K | 0.38% | 99 |
|
|
2015
Q2 | $4.85M | Buy |
41,405
+1,523
| +4% | +$166K | 0.45% | 82 |
|
|
2015
Q1 | $3.91M | Buy |
39,882
+519
| +1% | +$52.7K | 0.36% | 101 |
|
|
2014
Q4 | $3.71M | Buy |
+39,363
| New | +$4.07M | 0.36% | 99 |
|
|
2013
Q3 | – | Sell |
-27,599
| Closed | -$1.42M | – | 326 |
|
|
2013
Q2 | $1.42M | Buy |
+27,599
| New | +$1.44M | 0.13% | 189 |
|
Other funds holding GILD
VCM
VPM
Leuthold Group's GILD Position: Q1 2026 in Review
Leuthold Group increased its Gilead Sciences (GILD) stake by 1.9% in Q1 2026, buying an estimated $145K and bringing the position to 56,091 shares worth $7.82M. The position accounts for 0.83% of the portfolio, ranked #38.
Leuthold Group first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Leuthold Group held 56,091 shares of Gilead Sciences worth $7.82M as of Q1 2026.
- Leuthold Group bought 1,033 Gilead Sciences shares in Q1 2026, an estimated $145K.
- Gilead Sciences made up 0.83% of Leuthold Group's portfolio in Q1 2026, its #38 holding.
- Leuthold Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.